Veterinary Vertex

Send us Fan Mail
Hookworm cases that “just won’t clear” are no longer a weird outlier, and that should change how we practice. We sit down with parasitology expert Dr. Ray Kaplan to unpack the American Association of Veterinary Parasitologists (AAVP) Hookworm Task Force recommendations on diagnosing and treating multidrug-resistant canine hookworms, including what clinics can do right now to stop guessing and start confirming.

We talk through how this problem came to light, why drug-resistant hookworms likely gained traction in greyhound breeding and racing environments, and why it’s now a pet dog problem across breeds and regions. We also zoom out to the biology that makes Ancylostoma caninum such a persistent threat, from multiple routes of infection to the possibility of “larva leak,” and then get practical about what should raise suspicion. 

From there, we map out a clear diagnostic path. We discuss the value of a two-week post-treatment fecal recheck, how to use a fecal egg count reduction test to quantify efficacy, and what “good” reduction should look like. We cover the task force approach to treatment and testing across the three drug classes (topical moxidectin, pyrantel, and benzimidazoles like fenbendazole or febantel), the limits of current PCR testing, and when extra-label emodepside enters the conversation with important safety precautions. If you want a grounded, clinic-ready framework that also addresses environmental contamination and zoonotic risk, this one’s for you. 

Subscribe for more evidence-driven veterinary conversations, share this with a colleague who’s seeing chronic hookworm cases, and leave us a rating and review to help more listeners find the show.
JAVMA article: https://doi.org/10.2460/javma.26.02.0094
INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?
JAVMA ® : https://avma.org/JAVMAAuthors
AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :
Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook
Instagram: JAVMA (@avma_javma) • Instagram photos and videos
Twitter: JAVMA (@AVMAJAVMA) / Twitter
 
AJVR ® : 
Facebook: American Journal of Veterinary Research - AJVR | Facebook
Instagram: AJVR (@ajvroa) • Instagram photos and videos
Twitter: AJVR (@AJVROA) / Twitter

JAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals

Send us Fan Mail
A dog needs a pacemaker, the estimate is five figures, and the family’s last lifeline is a GoFundMe link. We wanted to know what happens next when veterinary teams suggest crowdfunding as a way to cover the cost of canine pacemaker implantation and whether it truly works often enough to be responsible advice.

We sit down with cardiologist and researcher Dr. Mark Rishniw to break down what he found by mining publicly available GoFundMe campaigns for dog pacemakers. We talk about how “success” gets defined, why reaching 80% of a target can still be a huge gap, and the uncomfortable headline: only a small slice of campaigns come close, while many never reach even half of what they ask for and some raise nothing at all. We also explore a pattern that changes the timeline for decision-making, with most donations arriving early and then fading fast.

From there, we widen the lens to the rising cost of advanced veterinary procedures, the reality that some interventions now rival the price of a car, and what that means for client conversations when the choices feel like treatment or euthanasia. We also discuss where pet insurance fits, why “friends and family” may be the true engine of most fundraising, and how to set expectations without taking hope away.

If you’ve ever wondered what to tell a client considering veterinary crowdfunding, this one will give you data and language you can use. Subscribe, share this with your team, and leave us a rating and review on Apple Podcasts or wherever you listen.
JAVMA article: https://doi.org/10.2460/javma.26.03.0160
INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?
JAVMA ® : https://avma.org/JAVMAAuthors
AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :
Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook
Instagram: JAVMA (@avma_javma) • Instagram photos and videos
Twitter: JAVMA (@AVMAJAVMA) / Twitter
 
AJVR ® : 
Facebook: American Journal of Veterinary Research - AJVR | Facebook
Instagram: AJVR (@ajvroa) • Instagram photos and videos
Twitter: AJVR (@AJVROA) / Twitter

JAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals

Send us Fan Mail
A lot of researchers quietly struggle with the same question: when is a study truly ready to publish, and how do you write it so someone actually uses it? From the AVMA Convention 2026, we sit down live with Dr. Joshua Stern, a veterinary cardiologist and geneticist whose work bridges cardiovascular disease, genomics, and clinical impact.

We start with Joshua’s path into cardiology, sparked by working with “super athlete” animals like racehorses and sled dogs, then move into what he learned from publishing early in his career, including a genetic screening project in boxer dogs that came back completely negative. The twist: those results still mattered, and they taught him how to frame significance, define impact, and tell the truth clearly without overselling. We also talk about how to decide when to stop collecting “just one more” datapoint and instead share findings that can help patients, clinicians, and other researchers now.

From there, we get practical about scientific writing and peer review. We unpack how to distill complex datasets into an approachable manuscript, when to move tables and niche analyses into supplementary materials, and why a massive supplement can be a sign you’re trying to write two papers. Joshua also shares his go-to mindset for reviewing and responding to reviews, including the simple habit of reading critiques, walking away, and coming back with a clearer lens. We close with a research challenge he hopes the field tackles next: the optimal timing of medical or surgical intervention in dogs and cats as advanced therapies expand.

If you care about veterinary research, manuscript publishing, and clinician-scientist career skills, subscribe, share this with a colleague, and leave us a review with your biggest peer review lesson.
INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?
JAVMA ® : https://avma.org/JAVMAAuthors
AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :
Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook
Instagram: JAVMA (@avma_javma) • Instagram photos and videos
Twitter: JAVMA (@AVMAJAVMA) / Twitter
 
AJVR ® : 
Facebook: American Journal of Veterinary Research - AJVR | Facebook
Instagram: AJVR (@ajvroa) • Instagram photos and videos
Twitter: AJVR (@AJVROA) / Twitter

JAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals

Send us Fan Mail
Your research might be solid, your conclusions might be exciting, and you still may be setting yourself up for a rough peer review if the methods, statistical analysis, and journal fit aren’t dialed in. Recording live from the AVMA 2026 convention in Anaheim, we sit down with Dr. Jolle Kirpensteijn, a longtime veterinary surgeon and associate editor, to unpack what actually speeds up (or stalls) publication in veterinary journals like JAVMA and AJVR. 

We get specific about the behind-the-scenes signals editors look for right away: study design clarity, sample size thinking, appropriate statistical tests, and whether the discussion stays relevant instead of inflating claims. Jolle explains why selecting a journal early and writing for a defined audience can prevent avoidable rewrites, and how improvements like faster time to publication can change an author’s entire submission strategy, especially for early-career veterinarians navigating deadlines and credentialing pressure. 

We also dig into the emotional side of publishing: that first brutal review, the temptation to get defensive, and the simple habits that separate a strong revision from a red-flag response. You’ll leave with a practical writing workflow (starting with Materials and Methods), a reminder that good research can matter more than flashy results, and clear guidance on making your abstract and cover letter do real work. 

If you found this helpful, subscribe for weekly conversations with the people shaping veterinary research, share this episode with a colleague who’s writing a paper, and leave a review telling us what publishing question you want answered next.
INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?
JAVMA ® : https://avma.org/JAVMAAuthors
AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :
Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook
Instagram: JAVMA (@avma_javma) • Instagram photos and videos
Twitter: JAVMA (@AVMAJAVMA) / Twitter
 
AJVR ® : 
Facebook: American Journal of Veterinary Research - AJVR | Facebook
Instagram: AJVR (@ajvroa) • Instagram photos and videos
Twitter: AJVR (@AJVROA) / Twitter

JAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals

Send us Fan Mail
Chronic laminitis forces every equine clinician into the same hard question: when comfort keeps slipping and radiographs keep worsening, what can truly change the mechanics of the foot and the horse’s day-to-day life? We sit down with Dr. Jim Orsini to talk about deep digital flexor (DDF) tenotomy, a procedure many people still treat as “last resort,” and why the data argue it may deserve earlier consideration in the right chronic rotational laminitis cases.

We dig into what the surgery is actually trying to accomplish: reducing the pull of the deep digital flexor tendon on the coffin bone (third phalanx) so the foot can realign to the ground surface. Jim walks us through the patient selection details that matter, including the rotation versus sinking distinction, and why great farriery is not optional. We also discuss the practical, clinic-friendly ways to judge success, from owner-observed comfort and stable pain-medication needs to radiographic progression like lysis, sole penetration, and hoof wall separation.

Then we get into the findings that made us pause, including the striking improvement signal at three to six months and the nuance around age, underlying causes like equine metabolic syndrome, and why chronic cases can be recognized late. We close with the real-world conversation every veterinarian has to have: cost, expectations, and the truth that chronic laminitis care is a long-term commitment, not a one-and-done fix.

Subscribe for more equine veterinary surgery and lameness insights, share this with a colleague or farrier you trust, and leave a rating and review so more listeners can find Veterinary Vertex.
JAVMA article: https://doi.org/10.2460/javma.25.12.0839
INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?
JAVMA ® : https://avma.org/JAVMAAuthors
AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :
Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook
Instagram: JAVMA (@avma_javma) • Instagram photos and videos
Twitter: JAVMA (@AVMAJAVMA) / Twitter
 
AJVR ® : 
Facebook: American Journal of Veterinary Research - AJVR | Facebook
Instagram: AJVR (@ajvroa) • Instagram photos and videos
Twitter: AJVR (@AJVROA) / Twitter

JAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals